ReviewInternational journal of molecular sciences2022

Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer.

Yifan Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.